Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5108 studies found for:    University of Maryland, Baltimore
Show Display Options
Rank Status Study
1 Unknown  The Therapeutic Workplace Intervention in Community Settings
Conditions: Drug Abuse;   Alcohol Abuse
Intervention: Behavioral: Community Therapeutic Workplace
2 Unknown  Treatment for Men Who Are Abusive to Their Partners
Condition: Domestic Violence
Intervention: Behavioral: Individual Cognitive Behavioral Therapy
3 Active, not recruiting Regulation of Endothelial Progenitor Cells by Short-Term Exercise
Conditions: Aging;   Exercise;   Cardiovascular Disease
Interventions: Other: Exercise Training;   Other: Exercise Cessation
4 Terminated Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa
Condition: Shigella
Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine;   Other: Placebo
5 Completed Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP
Condition: Shigella
Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine;   Other: Placebo
6 Unknown  Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection
Condition: Salmonella
Interventions: Biological: CVD 1902, a Salmonella enterica Serovar Paratyphi A live, oral vaccine;   Other: Placebo
7 Terminated Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb
Condition: Shigella
Intervention: Biological: CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
8 Completed Bupivacaine Versus Lidocaine on Inflammatory Regulation Following Endodontic Surgery
Condition: Pain
Interventions: Drug: Lidocaine;   Drug: Bupivacaine
9 Unknown  Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients
Conditions: Schizophrenia;   Mood Disorders;   Substance Dependence
Interventions: Behavioral: Behavioral Treatment for Substance Abuse in SPMI (BTSAS);   Behavioral: Supportive Treatment in Addiction Recovery (STAR);   Behavioral: Critical Time Intervention (CTI)
10 Not yet recruiting Dose Response of Epinephrine
Condition: Diabetes Complications
Interventions: Drug: Epinephrine;   Other: Saline infusion
11 Not yet recruiting TMS for Symptom Reduction in Schizophrenia
Condition: Schizophrenia and Related Disorders
Interventions: Device: Active rTMS stimulation;   Device: Sham rTMS stimulation
12 Recruiting CNS Sarcoidosis and Acthar Gel
Condition: CNS Sarcoidosis
Intervention: Drug: H.P. Acthar Gel
13 Recruiting GLP-1 and Hypoglycemia
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Glucagon-Like Peptide- 1 (GLP-1) infusion;   Other: Placebo Comparator: Saline Infusion
14 Recruiting Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)
Conditions: Type 1 Diabetes;   Hypoglycemia Associated Autonomic Failure
Interventions: Drug: Fluoxetine;   Drug: Placebo control
15 Completed
Has Results
Enhanced Room Cleaning in Intensive Care Units to Reduce Gown and Glove Contamination With Multi-drug-resistant Bacteria
Condition: Infection Control
Interventions: Other: Enhanced cleaning of surfaces in ICU rooms;   Other: Sham enhanced cleaning of surfaces in ICU rooms
16 Completed Mobile Diabetes Management
Condition: Diabetes
Interventions: Device: Tailored Patient Intervention;   Device: Patient-physician intervention;   Device: Patient and PCP intervention with analyzed data
17 Active, not recruiting Effects of Galantamine on Cognition
Condition: Schizophrenia
Interventions: Drug: Galantamine;   Drug: Galantamine or Placebo
18 Recruiting Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes
Interventions: Drug: Dehydroepiandrosterone;   Drug: Placebo
19 Terminated
Has Results
Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
Condition: Metabolic Syndrome
Interventions: Drug: Ramipril;   Drug: HCTZ-hydrochlorothiazide;   Drug: Ramipril+HCTZ
20 Active, not recruiting Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
Condition: Type 1 Diabetes
Interventions: Drug: Alprazolam;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.